InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: jessellivermore post# 198215

Monday, 06/24/2019 3:50:33 PM

Monday, June 24, 2019 3:50:33 PM

Post# of 425619
This drug is made to lower blood sugar. I do not see it as a competitor. Reduce-it protocol was for Vascepa to be taken on top of diabetes medication in diabetics. Vascepa would reduce risk above and beyond what this drug would do. It is likely there were people in the Reduce-it trial that would have been on this drug or similar drugs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News